CD276 and neoplasm: To evaluate the antitumor activity of CCR2b engineered B7-H3.CAR-T cells, we cocultured them with tumor cells and found that CCR2b coexpression did not hamper their antitumor activity, cytokine release, and proliferative capacity in vitro (Fig. 4d–g).